IsoTis OrthoBiologics Announces Final Resolution Of AFM Matter

Published: Sep 15, 2006

LAUSANNE, SWITZERLAND, and IRVINE, CA, Sept. 15 /CNW/ - IsoTis S.A. (SWX/Euronext: ISON; TSX: ISO), the orthobiologics company, today announced that the amount of the fine for the timing of regulatory filings to the AFM regarding the merger of IsoTis N.V. and IsoTis S.A. (at that time named Modex Therapeutics S.A.) in 2002 has been set by the administrative Court of Appeal in the Netherlands at EUR 326,715 for IsoTis N.V. and IsoTis S.A. As previously reported, the Company recorded a provision for the total amount of the potential liability, EUR 653,430 (EUR 326,715 for each company).

Back to news